Mesalazine A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Chronic Inflammatory Bowel Disease
- 1 October 1989
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 38 (4), 500-523
- https://doi.org/10.2165/00003495-198938040-00003
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using99mTc-labeled 5-ASA suppositoriesDigestive Diseases and Sciences, 1987
- Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitisDigestive Diseases and Sciences, 1987
- Proctocolitis unresponsive to conventional therapyDigestive Diseases and Sciences, 1987
- 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in CanadaDigestive Diseases and Sciences, 1987
- Possible mode of action of 5-aminosalicylic acidDigestive Diseases and Sciences, 1987
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic AcidClinical Pharmacokinetics, 1985
- Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in manEuropean Journal of Clinical Pharmacology, 1983
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980